Solomon Nwaka

3.1k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Solomon Nwaka is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Infectious Diseases. According to data from OpenAlex, Solomon Nwaka has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 7 papers in Parasitology and 6 papers in Infectious Diseases. Recurrent topics in Solomon Nwaka's work include Biotechnology and Related Fields (9 papers), Malaria Research and Control (7 papers) and Parasites and Host Interactions (7 papers). Solomon Nwaka is often cited by papers focused on Biotechnology and Related Fields (9 papers), Malaria Research and Control (7 papers) and Parasites and Host Interactions (7 papers). Solomon Nwaka collaborates with scholars based in Switzerland, United Kingdom and United States. Solomon Nwaka's co-authors include Alan L. Hudson, Reto Brun, David A. Fidock, Simon L. Croft, Philip J. Rosenthal, Robert G. Ridley, Bernadette Ramirez, Foluke Fakorede, Louis Maes and Q. D. Bickle and has published in prestigious journals such as Nature, The Lancet and Nature Reviews Drug Discovery.

In The Last Decade

Solomon Nwaka

25 papers receiving 2.0k citations

Hit Papers

Antimalarial drug discovery: efficacy models for compound... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Solomon Nwaka Switzerland 17 1.1k 484 460 405 377 26 2.1k
Pedro Cravo Portugal 28 1.4k 1.3× 484 1.0× 319 0.7× 340 0.8× 378 1.0× 76 2.3k
Michael K. Riscoe United States 31 1.4k 1.3× 1.4k 2.8× 533 1.2× 666 1.6× 495 1.3× 83 3.4k
Miriam Krugliak Israel 25 1.6k 1.4× 819 1.7× 257 0.6× 236 0.6× 203 0.5× 52 2.5k
Norman C. Waters United States 33 1.5k 1.3× 902 1.9× 339 0.7× 457 1.1× 239 0.6× 84 2.8k
María Auxiliadora Dea‐Ayuela Spain 27 531 0.5× 564 1.2× 351 0.8× 321 0.8× 330 0.9× 81 2.0k
Tina S. Skinner‐Adams Australia 34 1.5k 1.3× 1.2k 2.5× 662 1.4× 467 1.2× 511 1.4× 88 3.2k
Annette Erhart Belgium 34 2.5k 2.2× 287 0.6× 178 0.4× 147 0.4× 644 1.7× 90 3.3k
Francisco‐Javier Gamo Spain 23 1.3k 1.1× 962 2.0× 314 0.7× 403 1.0× 158 0.4× 70 2.4k
Cecília P. Sanchez Germany 30 1.9k 1.7× 587 1.2× 244 0.5× 189 0.5× 276 0.7× 77 2.5k
Sylke Müller United Kingdom 42 1.6k 1.4× 2.2k 4.5× 577 1.3× 307 0.8× 599 1.6× 77 3.8k

Countries citing papers authored by Solomon Nwaka

Since Specialization
Citations

This map shows the geographic impact of Solomon Nwaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solomon Nwaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solomon Nwaka more than expected).

Fields of papers citing papers by Solomon Nwaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solomon Nwaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solomon Nwaka. The network helps show where Solomon Nwaka may publish in the future.

Co-authorship network of co-authors of Solomon Nwaka

This figure shows the co-authorship network connecting the top 25 collaborators of Solomon Nwaka. A scholar is included among the top collaborators of Solomon Nwaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solomon Nwaka. Solomon Nwaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nwaka, Solomon. (2021). Social and Technological Innovation in Africa. 1 indexed citations
2.
Kassegne, Kokouvi, Ting Zhang, Shen‐Bo Chen, et al.. (2017). Study roadmap for high-throughput development of easy to use and affordable biomarkers as diagnostics for tropical diseases: a focus on malaria and schistosomiasis. Infectious Diseases of Poverty. 6(1). 130–130. 12 indexed citations
3.
Molette, Jérôme, Nada Abla, Dominique Besson, et al.. (2013). Identification and Optimization of an Aminoalcohol-Carbazole Series with Antimalarial Properties. ACS Medicinal Chemistry Letters. 4(11). 1037–1041. 37 indexed citations
4.
Nwaka, Solomon, Alexander Ochem, Dominique Besson, et al.. (2012). Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent. BMC International Health and Human Rights. 12(1). 11–11. 39 indexed citations
5.
Addae‐Mensah, Ivan, et al.. (2011). Traditional medicines as a mechanism for driving research innovation in Africa. Malaria Journal. 10(S1). S9–S9. 42 indexed citations
6.
Jakobsen, Palle, Ming‐Wei Wang, & Solomon Nwaka. (2011). Innovative Partnerships for Drug Discovery against Neglected Diseases. PLoS neglected tropical diseases. 5(9). e1221–e1221. 29 indexed citations
7.
Peeling, Rosanna Ŵ. & Solomon Nwaka. (2011). Drugs and Diagnostic Innovations to Improve Global Health. Infectious Disease Clinics of North America. 25(3). 693–705. 10 indexed citations
8.
Nwaka, Solomon, et al.. (2010). Developing ANDI: A Novel Approach to Health Product R&D in Africa. PLoS Medicine. 7(6). e1000293–e1000293. 53 indexed citations
9.
Crowther, Gregory J., Dhanasekaran Shanmugam, Santiago J. Carmona, et al.. (2010). Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach. PLoS neglected tropical diseases. 4(8). e804–e804. 115 indexed citations
10.
Nwaka, Solomon, Ian Bathurst, Michael Lanzer, et al.. (2010). CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malaria Journal. 9(1). 202–202. 6 indexed citations
11.
Zhang, Yiqun, W. Armand Guiguemde, Martina Sigal, et al.. (2010). Synthesis and structure–activity relationships of antimalarial 4-oxo-3-carboxyl quinolones. Bioorganic & Medicinal Chemistry. 18(7). 2756–2766. 41 indexed citations
12.
Nwaka, Solomon, Bernadette Ramirez, Reto Brun, et al.. (2009). Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression. PLoS neglected tropical diseases. 3(8). e440–e440. 128 indexed citations
13.
Ridley, Robert G., et al.. (2009). The African Network for Drugs and Diagnostics Innovation. The Lancet. 373(9674). 1507–1508. 33 indexed citations
14.
Ramirez, Bernadette, et al.. (2007). Schistosomes: challenges in compound screening. Expert Opinion on Drug Discovery. 2(sup1). S53–S61. 124 indexed citations
15.
Hopkins, Andrew L., Michael J. Witty, & Solomon Nwaka. (2007). Mission possible. Nature. 449(7159). 166–169. 29 indexed citations
16.
17.
Nwaka, Solomon & Alan L. Hudson. (2006). Innovative lead discovery strategies for tropical diseases. Nature Reviews Drug Discovery. 5(11). 941–955. 432 indexed citations
18.
Nwaka, Solomon. (2005). Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99. 20–29. 33 indexed citations
19.
Fidock, David A., Philip J. Rosenthal, Simon L. Croft, Reto Brun, & Solomon Nwaka. (2004). Antimalarial drug discovery: efficacy models for compound screening. Nature Reviews Drug Discovery. 3(6). 509–520. 663 indexed citations breakdown →
20.
Nwaka, Solomon, Lise Riopel, David Ubben, & J. Carl Craft. (2004). Medicines for Malaria Venture new developments in antimalarials. Travel Medicine and Infectious Disease. 2(3-4). 161–170. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026